STOCK TITAN

Ridgetech, Inc. (RDGT) Financials

RDGT
FY2026 annual
Revenue $132.2M +10.2% YoY
Net Income -$1.3M -112.3% YoY
EPS (Diluted) -$17.21 YoY not available
Free Cash Flow -$1.4M -227.6% YoY
Market Cap $3.0M as of Sep 15, 2026
Price / Sales 0.0x on $132.2M revenue, FY2026
Price / Earnings n/m net loss, so no earnings multiple, FY2026
Price / Book 0.1x on $40.8M equity, Q4 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 15, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2026, ended Mar 31, 2026 Reported Currency USD FYE March

Newest figures come from the 20-F for FY2026, filed Jul 31, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the RDGT SEC filings page.

Ridgetech, Inc. (RDGT) reported $132.2M in revenue for fiscal year 2026, up 10.2% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI RDGT FY2026

Ridgetech's balance-sheet repair outpaced its return to profitability, while thin gross margins kept operations cash-sensitive.

Financial flexibility improved materially: debt-to-equity fell from 5.2x in FY2024 to 0.7x in FY2026, reducing reliance on liabilities. Over the same span, current ratio rose from 0.9x to 2.3x, indicating more short-term asset coverage even as profitability remained negative.

Revenue recovered above FY2023's level by FY2026, but gross margin reached only 3.6% versus 3.0% in FY2023; the sales recovery therefore produced little cushion after direct costs. Operating margin was still -1.4% in FY2026, showing that the narrow gross-profit layer did not absorb overhead.

Cash conversion reversed: operating cash flow moved from $1.2M in FY2025 to -$1.4M in FY2026, putting reported earnings and cash generation back on the same weak side. Because free cash flow was -$1.4M while capital expenditures were only $449K, the shortfall was operational rather than investment-led.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 44 / 100
Financial Health Score 44/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Ridgetech, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
96

Ridgetech, Inc. held $17.9M in cash, cash equivalents and investments at the end of fiscal year 2026, and its operations used $1.4M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Ridgetech, Inc. scores 96/100 among other emerging companies.

Dilution
2

Ridgetech, Inc. had 133M shares outstanding at the end of fiscal year 2026. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Ridgetech, Inc. scores 2/100 among other emerging companies.

R&D Intensity
0

Not available for Ridgetech, Inc., and counted as zero in the overall score.

Revenue Progress
47

Ridgetech, Inc. reported revenue of $132.2M in fiscal year 2026, against $120.0M in fiscal year 2025. Revenue Progress ranks emerging companies on the three-year path of that line, and Ridgetech, Inc. scores 47/100 among other emerging companies.

Burn Trend
73

Ridgetech, Inc.'s operations used $1.4M of cash in fiscal year 2026, against $1.2M generated in fiscal year 2025. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Ridgetech, Inc. scores 73/100 among other emerging companies.

Balance Sheet
48

Ridgetech, Inc.'s cash, cash equivalents and investments came to $17.9M at the end of fiscal year 2026, against $28.3M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Ridgetech, Inc. scores 48/100 among other emerging companies.

Altman Z-Score Distress
1.22

Ridgetech, Inc. scores 1.22, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
3/8

Ridgetech, Inc. passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). No profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality No Cash Backing
N/A

Ridgetech, Inc. reported a net loss of $1.3M while operations used $1.4M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Ridgetech, Inc. reported an operating loss of $1.9M against $67K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q4 2026.

Cash & Balance Sheet

Cash & Debt
$17.9M
YoY+40.1%
QoQ+28.5%

Ridgetech, Inc. held $17.9M in cash as of Q4 2026; long-term debt is not reported for that period.

Shares Outstanding
133M

Ridgetech, Inc. had 133M shares outstanding in Q4 2026.

Free Cash Flow

Not reported for Q4 2026.

Dividends Per Share

Not reported for Q4 2026.

Margins & Returns

None of these metrics is reported for Q4 2026.

Capital Allocation

None of these metrics is reported for Q4 2026.

RDGT Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RDGT quarterly income statement
MetricQ4'2620-FQ2'266-KQ4'2520-FQ2'2510-QQ4'2410-KQ2'2410-QQ4'2310-KQ4'2210-K

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

RDGT Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RDGT quarterly balance sheet
MetricQ4'2620-FQ2'266-KQ4'2520-FQ2'2510-QQ4'2410-KQ2'2410-QQ4'2310-KQ4'2210-K
Total Assets$69.0M+7.0%$61.4M-34.8%$64.5M-32.2%$94.2M-0.6%$95.1M+4.5%$94.8M$91.0M-14.5%$106.4M+0.1%
Current Assets$64.6M+8.1%$56.7M-20.2%$59.7M-14.3%$71.1M+1.8%$69.7M+8.1%$69.8M$64.5M-14.4%$75.4M+4.3%
Cash & Equivalents$17.9M+40.1%$13.9M-22.6%$12.8M+456.3%$18.0M-3.5%$2.3M-87.8%$18.6M$18.8M+1.9%$18.5M-16.3%
Short-Term Investments$0$0$0$0$0$0$0$0
Inventory$8.3M-15.4%$9.2M-51.1%$9.8M+7.5%$18.8M-4.2%$9.1M-40.7%$19.6M$15.3M-4.4%$16.0M-5.6%
Accounts Receivable$32.5M+16.7%$26.5M+56.3%$27.8M+362.4%$16.9M-3.4%$6.0M-57.4%$17.5M$14.1M-15.6%$16.7M+24.7%
Long-Term Investments$0$0-100.0%$0-100.0%$1.2M+6.1%$1.2M-32.6%$1.2M$1.8M-60.8%$4.5M+13.4%
Goodwill$1.5M0.0%$1.5M$1.5MN/AN/AN/AN/AN/A
Total Liabilities$28.3M-18.9%$31.6M-57.3%$34.8M-56.9%$74.1M-4.1%$80.8M+8.7%$77.2M$74.3M-11.2%$83.6M+2.1%
Current Liabilities$27.9M-18.8%$31.1M-53.9%$34.4M-53.8%$67.5M-3.2%$74.4M+11.8%$69.8M$66.5M-10.6%$74.4M+14.7%
Non-Current Liabilities$356K-27.6%$485K-92.6%$492K-92.3%$6.5M-12.3%$6.4M-17.6%$7.4M$7.8M-15.5%$9.2M-45.9%
Total Equity$40.8M+37.6%$29.8M+38.7%$29.6M+89.5%$21.5M+13.7%$15.6M-13.2%$18.9M$18.0M-25.2%$24.1M-6.4%
Retained Earnings-$64.6M-2.0%-$63.4M+16.4%-$63.3M+13.9%-$75.8M-8.0%-$73.5M-6.1%-$70.2M-$69.3M-43.9%-$48.1M-7.1%

Not reported in any period shown, so not listed: Long-Term Debt.

RDGT Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RDGT quarterly cash flow statement
MetricQ4'2620-FQ2'266-KQ4'2520-FQ2'2510-QQ4'2410-KQ2'2410-QQ4'2310-KQ4'2210-K

Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

RDGT Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RDGT quarterly financial ratios
MetricQ4'2620-FQ2'266-KQ4'2520-FQ2'2510-QQ4'2410-KQ2'2410-QQ4'2310-KQ4'2210-K
Current Ratio2.31+0.6x1.82+0.8x1.74+0.8x1.05+0.1x0.940.0x1.000.970.0x1.01-0.1x
Debt-to-Equity0.69-0.5x1.06-2.4x1.18-4.0x3.45-0.6x5.16+1.0x4.094.12+0.7x3.47+3.4x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Ridgetech, Inc. RDGT FY2026 $132.2M -$1.3M -0.9% $3.0M 44/100
Cellyan Biotechnology Co., Ltd HKPD FY2025 $20.3M -$27K -0.1% $6.2M 49/100
Scienture Holdings, Inc. SCNX FY2025 $432K -$41.5M N/A $14.3M
PetMed Express, Inc. PETS FY2026 $179.0M -$57.3M -32.0% $35.8M 26/100
Wellgistics Health, Inc. WGRX FY2025 $23.3M -$101.3M N/A $8.8M 25/100

Frequently Asked Questions

What is Ridgetech, Inc.'s annual revenue?

Ridgetech, Inc. (RDGT) reported $132.2M in total revenue for fiscal year 2026. This represents a 10.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Ridgetech, Inc.'s revenue growing?

Ridgetech, Inc. (RDGT) revenue grew by 10.2% year-over-year, from $120.0M to $132.2M in fiscal year 2026.

Is Ridgetech, Inc. profitable?

No, Ridgetech, Inc. (RDGT) reported a net income of -$1.3M in fiscal year 2026, with a net profit margin of -0.9%.

Ridgetech, Inc. (RDGT) reported diluted earnings per share of -$17.21 for fiscal year 2026. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Ridgetech, Inc. (RDGT) had EBITDA of -$1.5M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

Ridgetech, Inc. (RDGT) had a gross margin of 3.6% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

Ridgetech, Inc. (RDGT) had an operating margin of -1.4% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

Ridgetech, Inc. (RDGT) had a net profit margin of -0.9% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Ridgetech, Inc. (RDGT) has a return on equity of -3.1% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

Ridgetech, Inc. (RDGT) recorded an outflow of $1.4M in free cash flow during fiscal year 2026. This represents a -227.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Ridgetech, Inc. (RDGT) recorded an outflow of $1.4M in operating cash flow during fiscal year 2026, representing cash used by core business activities.

Ridgetech, Inc. (RDGT) had $69.0M in total assets as of fiscal year 2026, including both current and long-term assets.

Ridgetech, Inc. (RDGT) invested $449 in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

Ridgetech, Inc. (RDGT) had 133M shares outstanding as of fiscal year 2026.

Ridgetech, Inc. (RDGT) had a current ratio of 2.31 as of fiscal year 2026, which is generally considered healthy.

Ridgetech, Inc. (RDGT) had a debt-to-equity ratio of 0.69 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

Ridgetech, Inc. (RDGT) had a return on assets of -1.8% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

Ridgetech, Inc. (RDGT) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2026). The market capitalization is $3.0M as of Sep 15, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Ridgetech, Inc. (RDGT) trades at 0.0x sales, its market capitalization divided by revenue of $132.2M revenue, FY2026. The market capitalization is $3.0M as of Sep 15, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Ridgetech, Inc. (RDGT) has an Altman Z-Score of 1.22, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Ridgetech, Inc. (RDGT) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Ridgetech, Inc. (RDGT) reported a net loss of $1.3M while operations used $1.4M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Ridgetech, Inc. (RDGT) reported an operating loss of $1.9M against $67K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Ridgetech, Inc. (RDGT) scores 44 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top